Literature DB >> 19738019

Antimicrobial susceptibilities of Mycoplasma genitalium strains examined by broth dilution and quantitative PCR.

Ryoichi Hamasuna1, Jørgen Skov Jensen, Yukio Osada.   

Abstract

Only limited information regarding the antimicrobial susceptibilities of Mycoplasma genitalium is available because of difficulties in isolating M. genitalium strains from clinical specimens. Antimicrobial susceptibilities of 15 clinical isolates, 7 ATCC strains, and an early passage of the M30 strain were examined by the broth dilution method. Azithromycin, clarithromycin, sitafloxacin, and moxifloxacin were the most active drugs against M. genitalium, and their MIC(90)s were 0.002, 0.008, 0.125, and 0.125 mg/liter, respectively.

Entities:  

Mesh：

Year:  2009        PMID： 19738019      PMCID： PMC2772321          DOI： 10.1128/AAC.00724-09

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  13 in total

1.  Emergence of macrolide-resistant Mycoplasma pneumoniae with a 23S rRNA gene mutation.

Authors:  Miyuki Morozumi; Keiko Hasegawa; Reiko Kobayashi; Nagako Inoue; Satoshi Iwata; Haruo Kuroki; Naohisa Kawamura; Eiichi Nakayama; Takeshi Tajima; Kouichi Shimizu; Kimiko Ubukata
Journal:  Antimicrob Agents Chemother       Date:  2005-06       Impact factor: 5.191

2.  Isolation of Mycoplasma genitalium from first-void urine specimens by coculture with Vero cells.

Authors:  Ryoichi Hamasuna; Yukio Osada; Jørgen Skov Jensen
Journal:  J Clin Microbiol       Date:  2007-01-24       Impact factor: 5.948

Review 3.  Mycoplasma genitalium infections. Diagnosis, clinical aspects, and pathogenesis.

Authors:  Jørgen Skov Jensen
Journal:  Dan Med Bull       Date:  2006-02

4.  Antibiotic susceptibility testing of Mycoplasma genitalium by TaqMan 5' nuclease real-time PCR.

Authors:  Ryoichi Hamasuna; Yukio Osada; Jørgen Skov Jensen
Journal:  Antimicrob Agents Chemother       Date:  2005-12       Impact factor: 5.191

5.  Isolation of Mycoplasma genitalium strains from the male urethra.

Authors:  J S Jensen; H T Hansen; K Lind
Journal:  J Clin Microbiol       Date:  1996-02       Impact factor: 5.948

6.  Pathogenic mycoplasmas: cultivation and vertebrate pathogenicity of a new spiroplasma.

Authors:  J G Tully; R F Whitcomb; H F Clark; D L Williamson
Journal:  Science       Date:  1977-03-04       Impact factor: 47.728

Review 7.  Guidelines and recommendations for antimicrobial minimum inhibitory concentration (MIC) testing against veterinary mycoplasma species. International Research Programme on Comparative Mycoplasmology.

Authors:  P C Hannan
Journal:  Vet Res       Date:  2000 Jul-Aug       Impact factor: 3.683

8.  Azithromycin treatment failure in Mycoplasma genitalium-positive patients with nongonococcal urethritis is associated with induced macrolide resistance.

Authors:  Jørgen S Jensen; Catriona S Bradshaw; Sepehr N Tabrizi; Christopher K Fairley; Ryoichi Hamasuna
Journal:  Clin Infect Dis       Date:  2008-12-15       Impact factor: 9.079

9.  Antibiotic treatment of symptomatic Mycoplasma genitalium infection in Scandinavia: a controlled clinical trial.

Authors:  E Björnelius; C Anagrius; G Bojs; H Carlberg; G Johannisson; E Johansson; H Moi; J S Jensen; P Lidbrink
Journal:  Sex Transm Infect       Date:  2007-10-11       Impact factor: 3.519

10.  Azithromycin failure in Mycoplasma genitalium urethritis.

Authors:  Catriona S Bradshaw; Jorgen S Jensen; Sepehr N Tabrizi; Timothy R H Read; Suzanne M Garland; Carol A Hopkins; Lorna M Moss; Christopher K Fairley
Journal:  Emerg Infect Dis       Date:  2006-07       Impact factor: 6.883
View more
  15 in total

1.  In vitro activity of five quinolones and analysis of the quinolone resistance-determining regions of gyrA, gyrB, parC, and parE in Ureaplasma parvum and Ureaplasma urealyticum clinical isolates from perinatal patients in Japan.

Authors:  Yasuhiro Kawai; Yukiko Nakura; Tetsu Wakimoto; Makoto Nomiyama; Tsugumichi Tokuda; Toshimitsu Takayanagi; Jun Shiraishi; Kenshi Wasada; Hiroyuki Kitajima; Tomio Fujita; Masahiro Nakayama; Nobuaki Mitsuda; Isao Nakanishi; Makoto Takeuchi; Itaru Yanagihara
Journal:  Antimicrob Agents Chemother       Date:  2015-02-02       Impact factor: 5.191

2.  Fluoroquinolone and macrolide resistance-associated mutations in Mycoplasma genitalium.

Authors:  Kaitlin A Tagg; Neisha J Jeoffreys; Deborah L Couldwell; Jennifer A Donald; Gwendolyn L Gilbert
Journal:  J Clin Microbiol       Date:  2013-05-08       Impact factor: 5.948

Review 3.  Mycoplasma genitalium: from Chrysalis to multicolored butterfly.

Authors:  David Taylor-Robinson; Jørgen Skov Jensen
Journal:  Clin Microbiol Rev       Date:  2011-07       Impact factor: 26.132

4.  In vitro activity of the new fluoroketolide solithromycin (CEM-101) against macrolide-resistant and -susceptible Mycoplasma genitalium strains.

Authors:  Jørgen Skov Jensen; Prabhavathi Fernandes; Magnus Unemo
Journal:  Antimicrob Agents Chemother       Date:  2014-03-17       Impact factor: 5.191

Review 5.  New Horizons in Mycoplasma genitalium Treatment.

Authors:  Catriona S Bradshaw; Jorgen S Jensen; Ken B Waites
Journal:  J Infect Dis       Date:  2017-07-15       Impact factor: 5.226

6.  Effect of gatifloxacin against Mycoplasma genitalium-related urethritis: an open clinical trial.

Authors:  Ryoichi Hamasuna; Satoshi Takahashi; Hiroshi Kiyota; Mitsuru Yasuda; Hiroshi Hayami; Soichi Arakawa; Kazunori Tomono; Tetsuro Matsumoto
Journal:  Sex Transm Infect       Date:  2011-04-28       Impact factor: 3.519

7.  Macrolide resistance-associated 23S rRNA mutation in Mycoplasma genitalium, Japan.

Authors:  Yasushi Shimada; Takashi Deguchi; Keita Nakane; Mitsuru Yasuda; Shigeaki Yokoi; Shin-Ichi Ito; Masahiro Nakano; Shin Ito; Hiroaki Ishiko
Journal:  Emerg Infect Dis       Date:  2011-06       Impact factor: 6.883

Review 8.  Mycoplasma genitalium infection: current treatment options, therapeutic failure, and resistance-associated mutations.

Authors:  Deborah L Couldwell; David A Lewis
Journal:  Infect Drug Resist       Date:  2015-05-26       Impact factor: 4.003

9.  Global fluoroquinolone resistance epidemiology and implictions for clinical use.

Authors:  Axel Dalhoff
Journal:  Interdiscip Perspect Infect Dis       Date:  2012-10-14

10.  Treatment of Mycoplasma genitalium. Observations from a Swedish STD clinic.

Authors:  Carin Anagrius; Britta Loré; Jørgen Skov Jensen
Journal:  PLoS One       Date:  2013-04-08       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.